drugset / Trial / NCT03779815

Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography

NCT03779815

Completed 14 enrolled Ulsan University Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

\[18F\]Florbetaben PET/CT imaging will noninvasively assess amyloid deposition in systemic amyloidosis.

Timeline

Start
2018-08-20
Primary completion
2019-02-28
Completion
2019-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-Florbetaben Diagnostic / imaging agent 300 mbq Intravenous

Indications